Cellscape Corporation
Newark, CA, US· latest recorded location
Cellscape Corporation is named on 2 US grants and 3 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 2
- Published applications
- 3
- Inventors
- 5
- Granted in 2026 so far
- 0
- Most recent grant
- 8 Jul 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
By publication year.
Technology areas
Share of 5 documents
Recent patents
- Method and device for identification of nucleated red blood cells from a maternal blood sample8 Jul 2014US 8,774,488 B2
- Method and device for identification of nucleated red blood cells from a maternal blood sample23 Apr 2013US 8,426,122 B2
- Method and Device for Identification of Nucleated Red Blood Cells from a Maternal Blood Sample26 Jan 2012US 2012/0021508 A1
- Method and Device for Identification of Nucleated Red Blood Cells from a Maternal Blood Sample22 Dec 2011US 2011/0311960 A1
- Methods and systems for genetic analysis of fetal nucleated red blood cells24 Jun 2010US 2010/0159506 A1
Most cited
By later US patents